Monique C.J. Hanse
Radboud University Nijmegen(NL)Catharina Ziekenhuis(NL)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Ferroptosis and cancer prognosis, Cancer, Hypoxia, and Metabolism, Radiomics and Machine Learning in Medical Imaging, Ubiquitin and proteasome pathways
Most-Cited Works
- → Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial(2014)745 cited
- → Transcriptome analysis reveals tumor microenvironment changes in glioblastoma(2023)235 cited
- → Molecular Evolution of IDH Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study(2019)116 cited
- → Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial(2016)99 cited
- → Recovery of Posterior Communicating Artery Aneurysm-Induced Oculomotor Palsy after Coiling(2008)75 cited
- → A pilot randomized controlled trial of exercise to improve cognitive performance in patients with stable glioma: a proof of concept(2019)71 cited
- → A randomized phase II study of bevacizumab versus bevacizumab plus lomustine versus lomustine single agent in recurrent glioblastoma: The Dutch BELOB study.(2013)61 cited
- → The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial(2015)59 cited
- → Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial(2017)53 cited
- → Antisaccades and remembered saccades in mild traumatic brain injury(2000)50 cited